Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset

The original manuscript did not include the list of PETACC8 investigators. The names are repeated below. PETACC-8 study investigators Country Group(s), Coordinator(s) Principle investigator(s) (Centre) Austria Austrian Breast and Colorectal cancer Study Group (ABCSG), Joseph Thaler Josef Thaler (KlinikumKreuzschwestern Wels, Wels); Richard Greil (LKH Salzburg); Johannes Gaenzer (BKH Hall in Tirol, Hall in Tirol); Wolfgang Eisterer (University Klinik Innsbruck, Innsbruck); JoergTschmelitsch (KH BarmherzigeBrüder St. Veit / Glan) Felix Keil (LKH Leoben, Leoben); HellmutSamonigg (Landeskrankenhaus Graz MedizinischeUniversitätsklinik, Graz); August Zabernigg (BKH Kufstein, Kuftstein); Franz Schmid (LKH Bregenz, Bregenz); Günther Steger (UniversitätsklinikfürInnereMedizin I, Wein); Robert Steinacher (LKH Wolfsberg, LKH); Johannes Andel (LKH Steyr, Steyr); BjörnJagdt, (a.ö.Krankenhaus d. Barmherz. Schwest. Ried, Ried); Alois Lang (LKH Rankweil, Rankweil), Michael Fridrik (AKH Linz, Linz); Reinhold Függer (A.ö. Krankenhaus d. Elisabethinen Linz); Friedrich Hofbauer (LKH Oberpullendorf, Oberpullendorf); EwaldWoell (KH St. VinzenzZams, Zams); DietmarGeissler (LKH Klagenfurt, Klagenfurt); Alfred Lenauer (KH Wiener Neustadt, Wiener Neustadt); Manfred Prager (A.ö. KH Oberwart, Oberwart) Belgium Belgian Group of Digestive Oncology (BGDO), Jean-Luc Van Laethem and Eric Van Cutsem Geert D'Haens (Imelda Ziekenhuis, Bonheiden); Gauthier Demolin (Clinique St-Jospeh, Liège); Joseph Kerger (CliniquesUniversitaires de Mont-Godinne U.C.L. Yvoir); Guido Deboever (A. Z. St-Jozef, Oostende); Gilbert Ghillebert (Heilig Hart Ziekenhuis, Roeselare); Marc Polus (C. H. U. Sart-Tilman, Liège); Eric Van Cutsem (University Hospitals, Leuven); Hassan RezaieKalantari (C. H. Peltzer-La Tourelle, Verviers); Thierry Delaunoit (Centre Hospitalier de Jolimont-Lobbes, La Louvière); Jean Charles Goeminne (Clinique et Maternité Sainte-Elisabeth, Namur); Marc Peeters (UniversitairZiekenhuis Gent, Gent); Philippe Vergauwe (AZ Groeninge-Campus Kennedylaan, Kortrijk); GhislainHoubiers (Centre médical de L'Avenue, Liege); Yves Humblet (CliniquesUniversitaires Saint-Luc, Brussels); Jos Janssens (St-Elisabeth Ziekenhuis, Turnhout); Dirk Schrijvers (ZNA Middelheim, Antwerpen); Erik Vanderstraeten (AZ Maria Middelares, Gent); Jean-Luc Van Laethem (ULB HôpitalErasme, Brussels); Jan Vermorken (UZ Antwerpen, Edegem); Daniel Van Daele (Clinique Nôtre-Dame de Grâce, Gosselies); Michel Ferrante (AZ Sint-Maarten, Mechelen); Frederic Forget (Centre Hospitalier de l'Ardenne, Libramont); Alain Hendlisz (Jules Bordetinstituut, Brussels) Denmark Lone Nørgård Petersen MetteYilmaz (Aalborg Sygehus-AfsnitSyd, Aalborg); Svend Erik Nielsen (Hillerød Hospital, Hillerød); LeneVestermark (Odense Universitets Hospital, Odense); Jim Larsen (Roskilde Amtssygehus, Roskilde) France Fédération Francophone de Cancérologie Digestive (FFCD), Jean François Seitz; Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER), Marc Ychou; Fédération Nationale des Centres de Lutte Contre le Cancer Association Européenne de Recherche en Oncologie (AERO), AymanZawadi Mohamed-AymanZawadi (Centre Hospitalier Les Oudairies, La Roche sur Yon); Olivier Bouche (CHU de Reims, Hopital Robert Debre, Reims); Laurent Mineur (Institut Sainte Catherine, Avignon); JaafarBennouna-Louridi (CRLCC René Gauducheau, St Herblain); Louis Marie Dourthe, (Clinique Sainte Anne, Strasbourg); Marc Ychou (Centre Regional Val d'Aurelle Paul Lamarque, Montpellier); Eveline Boucher (CRLC Eugène Marquis, Rennes); Julien Taieb (Hôpital Européen Georges Pompidou, Paris); Denis Pezet (CHU Estaing, Clermond Ferrand); FrancoiseDesseigne (Centre LeonBerard, Lyon); Michel Ducreux (Institut Gustave Roussy Villejuif); Patrick Texereau (HopitalLayne, Mont-de-Marsan); Laurent Miglianico (Centre Hospitalier Privé Saint- Grégoire (Rennes), Saint-Grégoire); Philippe Rougier (Hôpital Européen Georges Pompidou, Paris); Serge Fratte (Centre Hospitalier de Belfort-Montbeliard, Belfort); Charles-Briac Levache (Polyclinique Francheville, Perigueux); Yacine Merrouche, (Institut de Cancerologie de la Loire, Saint-Priest-En-Jarez); Stephen Ellis (Clinique Saint Pierre, Perpignan); Christophe Locher (CH Meaux, Meaux); Jean-FrancoisRamee (Centre Catherine de Sienne, Nantes); Claire Garnier (UMGEC-Institut Daniel Hollard, Grenoble); Frederic Viret (Institut Paoli Calmettes, Marseille); Bruno Chauffert (Centre Georges François Leclerc, Dijon); Isabelle Cojean-Zelek (Hopital Croix Saint Simon, Paris); Pierre Michel (Hopital Charles Nicolle, Rouen); Cedric Lecaille (Polyclinique Bordeaux Nord Aquitaine, Bordeaux); Christian Borel (CLCC Paul Strauss, Strasbourg); Jean-FrancoisSeitz (CHU de la Timone, Marseille); Denis Smith (Groupe Hospitalier Saint-Andre, Bordeaux); Catherine Lombard-Bohas (Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon); Thierry Andre (Groupe Hospitalier Pitie-Salpetriere, Paris); Jean-Marc Gornet, (Hopital Saint Louis, Paris); Francine Fein (CHU de Besancon, Hopital Jean Minjoz, Besançon); Marie-Aude Coulon-Sfairi (Centre Hospitalier du Mans, Le Mans); Marie-Christine Kaminsky (Centre Alexis Vautrin Brabois, Vandoeuvre les Nancy); Jean-Paul Lagasse (CHR d' Orléans La Source, Orléans); Dominique Luet (CRLCC Paul Papin, Angiers); Pierre-Luc Etienne (Clinique Armoricaine de Radiologie, Saint-Brieux); Mohamed Gasmi (Hopital Nord de Marseille, Marseille); AndreVanoli (Clinique Ste-Marie, Chalon Sur Saone); Suzanne Nguyen (Centre Hospitalier de Beauvais, Beauvais); Thomas Aparicio (Hôpital Bichat, Paris); Hervé Perrier (Hopital Saint Joseph, Marseille); Noel Stremsdoerfer (Hopital Pierre Oudot, Bourgoin-Jallieux); Philippe Laplaige (Clinique Saint Côme, La Chaussée St Victor); Dominique Arsene (CHU de Caen, Caen); Dominique Auby (Hôpital Robert Boulin, Libourne); Laurent Bedenne (Hopital du Bocage, Dijon); Romain Coriat (Hopital Cochin, Paris); Bernard Denis (Hopital Pasteur, Colmar); Patrick Geoffroy (Clinique Saint-Vincent, Epernay); Gilles Piot (Clinique des Ormeaux, Le Havre); Yves Becouarn (CHU de Bordeaux, Bordeaux); Gilbert Bordes (Centre Hospitalier de Digne Les Bains, Digne Les Bains); GaelDeplanque (Hopital Saint Joseph, Paris); Olivier Dupuis (Clinique Victor Hugo, Le Mans); FredericFruge (CHU Poitiers-Hôpital la Milétrie, Poitiers); Rosine Guimbaud (HopitalPurpan,Toulouse); Thierry Lecomte (Hopital Trousseau - CHU de Tours, Tours); Gérard Lledo (Hopital Prive Jean Mermoz, Lyon); IradejSobhani (Hôpital Henri Mondor (Gastro-Entérologie), Créteil); AmaniAsnacios (Hopital Antoine Beclere, Clamart); Ahmed Azzedine (Boulat, Michel, Avignon); Christophe Desauw (Hopital Saint Vincent de Paul-GHICL Lille, Lille); Marie-Pierre Galais (Centre François Baclesse, Caen); Dany Gargot (Centre Hospitalier de Blois, Blois); You-Heng Lam (Hopital de Cholet, Cholet); AbakarAbakar-Mahamat (Hopital l'Archet II, Nice); Jean-FrancoisBerdah (Clinique Sainte Marguerite, Hyères); Sylviane Catteau (Hopital Duchenne, Boulogne sur Mer); Marie-Christine Clavero-Fabri (Clinique Hartman, Levallois Perret); Jean-FrancoisCodoul (Hopital de Draguignan, Draguignan); Jean-Louis Legoux (Hôpital Haut Levêque, Pessac); Denis Goldfain (Centre Hospitalier General de Dreux, Dreux); Pierre Guichard (Clinique des quatre Pavillons, Lormont); Denis Pere Verge (Hôpital de la Croix Rousse (Gastroentérologie), Lyon); Jocelyne Provencal (Centre Hospitalier d'Annecy, Pringy); Bruno Vedrenne (Hopital E. Muller, Mulhouse); Catherine Brezault-Bonnet (Hopital de Rambouillet, Rambouillet); Denis Cleau (Centre Hospitalier Intercommunal de Vesoul, Vesoul); Jean-Paul Desir (Clinique Pole Sante Republique, Clermont-Ferrand); David Fallik (Polyclinic Jeanne d'Arc Gien); Bruno Garcia (Clinique de Courlancy, Reims); Marie-Hélène Gaspard (Clinique Claude Bernard, Albi); Dominique Genet (Centre de CancerologieChenieux, Limoges); Johannes Hartwig (Infirmerie Protestante de Lyon, Caluire et Cuire); Yves Krummel (Centre Hospitalier Selestat, Selestat); Tamara MatysiakBudnik (CH de Nantes Hotel Dieu, Nantes); Vanessa Palascak-Juif (Hopital de Hautepierre, Strasbourg); HarizoRandrianarivelo (Centre FredericJoliot, Rouen); Yves Rinaldi (Clinique Clairval, Marseille); Albert Aleba (Centre Hospitalier de Niort, Hopital Georges Renon, Niort); Ariane Darut-Jouve (Centre d'oncologie et Radiotherapie, Dijon); Aimery de Gramont (Hopital Saint Antoine, Paris); Herve Hamon (Centre Hospitalier de Valence, Valence); FredericWendehenne (Clinique Charcot, Sainte-Foy-les-Lyon) Germany ArbeitsgemeinschaftInternistischeOnkologie (AIO), GunnarFolprecht Axel Matzdorff (Caritasklinik St. Theresia, Saarbruecken); Michael Konrad Stahl (Kliniken Essen-Mitte–PS, Essen); Wolfgang Schepp (KKH MuenchenBogenhausen, Muenchen); Martin Burk (Klinikum der Stadt Hanau, Hanau); Lothar Mueller (OnkologischeSchwerpunktpraxis, Leer); Gunnar Folprecht (Universitaetsklinikum Carl Gustav Carus, Dresden); Michael Geissler (StaedtischeKliniken Esslingen, Esslingen); Luisa Mantovani-Loeffler (StaedtischesKlinikum St. Georg Leipzig, Leipzig); Thomas Hoehler (Prosper-Hospital, Recklinghausen); Walter Asperger (Krankenhaus St. Elisabeth und St. Barbara, Halle); HendrikKroening (Gemeinschaftspraxis, Magdeburg); Ludwig Fischer von Weikersthal (MVZ Gesundheitszentrum St. Marien GmbH, Amberg); Stefan Fuxius (Onkologische Praxis, Heidelberg); Matthias Groschek (Haematologisch-Onkologische Praxis Wuerselen, Wuelselen); Johannes Meiler, TanjaTrarbach (Universitaetsklinikum Essen, Essen); Jacqueline Rauh (GemeinschaftspraxisArdeystrasse, Witten); Nicolas Ziegenhagen, Albrecht Kretzschmar (Helios-Kliniken Berlin, Berlin); UllrichGraeven (Kliniken Maria Hilf GmbH, Moenchengladbach); ArndNusch (Onkologische Praxis, Velbert); Goetz von Wichert (Universitaetsklinikum, Ulm); Ralf-Dieter Hofheinz (Klinikum der Stadt Mannheim, Mannheim); Gerhard Kleber (Ostalb-Klinikum Aalen, Aalen); Karl-Heinz Schmidt (Johanniter-KrankenhausRheinhausen, Duisberg); Ursula Vehling-Kaiser (Gemeinschaftspraxis, Landshut); Claudia Baum, JochenSchuette (Marien Hospital Duesseldorf GmbH, Duesseldorf); Georg Martin Haag (Universitaetsklinikum Heidelberg, Heidelberg); Wilhelm Holtkamp (Ammerland-Klinik GmbH, Westerstede); JochenPotenberg (Evangelisches Waldkrankenhaus, Berlin); Tobias Reiber (Praxis fuer Haematologie/Onkologie, Freiberg); Georg Schliesser (Praxis fuerHaematologie und Onkologie, Giessen); Hans-Joachim Schmoll (Martin-Luther-Universitaet Halle-Wittenberg, Halle); Wolfgang Schneider-Kappus (Arztpraxis, Ulm); Wolfgang Abenhardt (Onkologie Praxis imElisenhof, Muenchen); Claudio Denzlinger (Marienhospital Stuttgart, Stuggart); Jan Henning, BartschtMarxsen (Universitaetsklinikum Schleswig-Holstein, Luebeck); Hans GuenterDerigs (StaedtischeKliniken Frankfurt-Hoechst, Frankfurt); Helmut Lambertz (Klinikum Garmisch-Partenkirchen, Garmisch-Partenkirchen); Ingulf Becker-Boost (MVZ Duisburg Sued GmbH, Duisburg); Karel Caca (Klinikum Ludwigsburg, Ludwigsburg); Christian Constantin (Kliniken Lippe-Lemgo GmbH, Lemgo); Thomas Decker (Gemeins chaftspraxis, Ravensburg); Henning Eschenburg (Internistische Gemeinschaftspraxis, Guestrow); SigrunGabius (Gemeinschaft spraxis, Rosenheim); HolgerHebart (KlinikumSchwaebisch Gmuend-Stauferklinik, Mutlangen); Albrecht Hoffmeister (Universitaetsklinikum Leipzig, Leipzig); Heinz-August Horst (Universitaetsklinikum Schleswig-Holstein-Campus Kiel, Kiel); Stephan Kremers (Caritas-Krankenhaus, Lebach); MalteLeithaeuser (Universitaetsmedizin Rostock, Rostock); Sebastian Mueller (AmbulantesOnkologieZentrum, Ansbach); Siegfried Wagner (KlinikumDeggendorf, Deggendorf); SeverinDaum (Charité Universitaetsmedizin Berlin-Campus CharitéMitte, Berlin); Frank Schlegel (St. Antonius-Hospital, Eschweiler); Martina Stauch (OnkologischeSchwerpunktpraxis, Kronach); Volker Heinemann (Klinikum der Ludwig-Maximilians-Universitaet, Muenchen) Italy Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente (GISCAD), Roberto Labianca; Gruppo Oncologico dell'Italia Meridionale (GOIM), Giuseppe Colucci; Istituto Oncologico Romagnolo (IOR), Dino Amadori; Gruppo Cooperativo Chirurgico Italiano (GOCCI), Enrico Mini; Gruppo Oncologico Nord Ovest (GONO), Alfredo Falcone; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Corrado Boni Evaristo Maiello (IRCCS Casa Sollievo della sofferenza, San Giovanni Rotondo); Luciano Latini (Ospedale di Macerata, Macerata); Alberto Zaniboni (Fondazione Poliambulanza Istituto Ospedaliero, Brescia); Dino Amadori (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola); Giuseppe Aprile (Az. Policlinico Universitario di Udine, Udine); Sandro Barni (Azienda Ospedaliera Treviglio-Caravaggio, Treviglio); Rodolfo Mattioli (Ospedale Santa Croce ASUR 3, Fano); Andrea Martoni (Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Ma, Bologna); Rodolfo Passalacqua (Azienda Ospedaliera Istituti Ospitalieri di Cremona, Cremona); Mario Nicolini, Enzo Pasquini (Ospedale Cervesi, Cattolica); Carla Rabbi, Enrico Aitini (Azienda Ospedaliera Carlo Poma, Mantova); Alberto Ravaioli (Ospedale degli Infermi, Rimini); Carlo Barone (Policlinico Universitario Agostino Gemelli, Roma); Guido Biasco (Ospedale Marcello Malpighi Policlinico Sant'Orsola, Bologna); Stefano Tamberi, Angelo Gambi (Ospedale Degli Infermi, Faenza); Claudio Verusio (Ospedale di Saronno, Saronno); Marina Marzola, Giorgio Lelli (Azienda Ospedaliera Universitaria Arcispedale Sant'Anna, Cona (Ferrara)); Corrado Boni (A.O. Arcispedale Santa Maria Nuova, Reggio Emilia); Stefano Cascinu (Azienda Ospedaliero Universitaria Ospedali Riuniti, Ancona); Paolo Bidoli, Massimo Vaghi (Azienda Ospedaliera San Gerardo, Monza); Giorgio Cruciani (Ospedale Umberto I, Luggo); Francesco Di Costanzo (Azienda Ospedaliera Universitaria Careggi, Firenze); Alberto Sobrero (Azienda Ospedaliera San Martino, Genoa); Enrico Mini (A.O. Universitaria Careggi, Firenze); Roberto Petrioli (A.O.U. Senese Policlinico Santa Maria alle Scotte, Siena); Massimo Aglietta (Istituto per la Ricerca e la Cura del Cancro, Candiolo); Oscar Alabiso (Ospedale Maggiore della Carità, Novara); Federico Capuzzo, Alfredo Falcone (Presidio Ospedaliero di Livorno, Livorno); Domenico Cristi Corsi (Ospedale "S. Giov. Calibita" Fatebenefratelli. Roma); Roberto Labianca (Ospedali Riuniti di Bergamo, Bergamo); Stefania Salvagni (Azienda Ospedaliera di Parma, Parma); Silvana Chiara (Istituto nazionale per la ricerca sul cancro, Genova) Libero Ciuffreda (A.O. San Giovanni Battista, Torino); Francesco Ferraù (Azienda Ospedaliera San Vincenzo, Taormina); Francesco Giuliani (Istituto Oncologico Giovanni Paolo II IRCCS, Bari); Sara Lonardi (IOV-Istituto Oncologico Veneto IRCCS, Padova); Nicola Gebbia (Azienda Ospedaliero Universitaria Policlinico Paolo Giaccone, Palermo); Giovanni Mantovani (Università di Cagliari-Presidio Policlinico Monserrato, Monserrato) Portugal Gruppo Cooperativo do Cancro Digestivo da Associação Portuguesa de InvestigaçãoOncológica (GCCD, APIO), Evaristo Sanches Evaristo Sanches (InstitutoPortuguês de Oncologia do Porto Francisco Gentil, Porto); Juan Carlos Mellidez (Hospital Distrital de Aveiro, Aveiro); Pedro Santos (Hospital SãoSebastião, EPE, Santa Maria da Feira); Joao Freire (InstitutoPortugues de Oncologia, Lison); Cristina Sarmento (Hospital de Sao Joao, Porto); Luis Costa (Hospital de Santa Maria, Lisbon); Antonio Moreira Pinto (Hospital Geral de Santo Antonio, Porto); Sergio Barroso (Hospital Distrital de Beja, Beja); Jorge Espirito Santo (Hospital do Barreiro, Barreiro); FátimaGuedes (Hospital DistritalFigueira da Foz, EPE, Figueira da Foz); Amélia Monteiro (Hospital SãoTeotónio, EPE, Viseu); Anabela Sa (Hospitais da Universidade de Coimbra, Coimbra); Irene Furtado (Hospital Distrital de Faro, Faro) Spain GrupoEspañol para elTratamiento de losTumoresDigestivos (TTD), Josep Tabernero Ramon Salazar (ICO ĺHospitalet Hospital Duran iReynals, Barcelona); EnriqueArandaAguilar (Hospital Reina Sofia, Cordoba); Fernando Rivera Herrero (Hospital Universitario Marques de Valdecilla, Santander); Josep Tabernero (Hospital. Vall d'Hebron, Barcelona); Javier Sastre Valera (Hospital Clinico San Carlos, Madrid); Manuel ValladaresAyerbes (ComplejoHospitalario Universitario A Coruña, A Coruña); Jaime FeliuBatlle (Hospital Universitario La Paz, Madrid); Silvia Gil (Hospital Carlos Haya, Malaga; Albert Abad Esteve (ICO Badalona-Hospital Germans Trias i Pujol, Barcelona); Carlos Garcia-Giron (Hospital Universitario de Burgos, Burgos); Guillermo Lopez Vivanco (Hospital de Cruces, Vizcaya); Antonia Salud Salvia (Hospital Universitario de Lleida Arnau de Vilanova, Lleida); Vicente Alonso Orduña (Hospital Miguel Servet, Zaragoza); Ruth Vera Garcia (ComplejoHospitalario de Navarra, Pamplona); Javier Gallego (HGU de Elche, Elche-Alicante); BartomeuMassutiSureda (Hospital General Universitario de Alicante, Alicante); Jordi Remon (Hospital de Mataro, Barcelona); Maria Jose Safont Aguilera (Hospital General Universitario de Valencia, Valencia); Luis CireraNogueras (Hospital Mutua de Terrassa, Barcelona); BernadoQueralt Merino (Hospital Universitari de Girona Dr Josep Trueta, Girona); Cristina Gravalos Castro (Hospital 12 de Octubre, Madrid); Purificacion Martinez de Prado (Hospital de Basurto, Bilbao); Carlos PijaumePericay (ConsorciHospitalariParcTauli, Barcelona); Manuel ConstenlaFigueiras (Hospital Provincial de Pontevedra, Pontevedra); InmaculadaGuasch Jordan (Hospital Sant Joan de Deu de Manresa, Manresa); Maria Jose GomeReina (Hospital del Mar, Cadiz); Amelia Lopez-Ladron Garcia (Hospital ElTomillar-NtraSra de Valme, Sevilla); Antonio Arrivi Garcia-Ramos (Fundacion Hospital Son Llatzer, Palma Mallorca); Andres Cervantes (Hospital Clinico Universitario de Valencia, Valencia); Carlos Fernandez Martos (InstitutoValenciano de Oncologia, Valencia); Eugenio MarcuelloGaspar (Hospital de la Santa Creu i Sant Pau, Barcelona); Ines Cabezas Montero (Hospital Universitario Sant Joan de Reus, Tarragona); Pilar EscuderoEmperador (Hospital Clinico Universitario Lozano Blesa, Zaragoza); Ana Leon Carbonero (Fundacion Jimenez Diaz, Madrid); Manuel Gallen Castillo (Hospital del Mar, Barcelona); Teresa Garcia Garcia (Hospital MoralesMeseguer, Murcia); Jose Garcia Lopez (Hospital Universitario Ramón y Cajal, Madrid); EncarnacionGonzalezFlores (Hospital Virgen de las Nieves Ruiz de Alda, Granada); Monica GuillotMorales (Hospital Son Espases, Palma de Mallorca); Marta LlanosMuñoz (Hospital Universitario de Canarias, Santa Cruz de Tenerife); Ana López Martín (Hospital Severo Ochoa); Joan Maurel (Hospital Clinic i Provincial, Barcelona); Juan Carlos Camara (Fundacion Hospital Alcorcon, Madrid); Rosario Dueñas Garcia (Hospital Ciudad de Jaen, Jaen); Mercedes Salgado (ComplejoHospitalario Ourense, Ourense); Isabel HernandezBusquier (Hospital ProvincialCastellon, Castellon); Teresa Checa Ruiz (Instituto de Oncologia Corachan, Barcelona); Adelaida LacastaMuñoa (Hospital. de Donostia, San Sebastian); MiquelNogueAliguer (Hospital General de Vic, Vic); Amalia Velasco Ortiz de Taranco (Hospital Universitario de La Princesa, Madrid); Miguel Mendez Ureña (Hospital General de Mostoles, Mostoles); Ferran Losa Gaspa (Consorci Sanitari CreuRoja, Barcelona); Jose Juan Ponce (Hospital Virgen de losLirios, Alicante); Carlos Bosch Roig (Hospital Universitario. Dr.Peset, Valencia); Pedro Valero Jimenez (Clínica Infanta Luisa, Sevilla); Antonio GalanBrotons (Hospital Sagunto, Sagunto); Santiago AlbiolRodriguez (Hospital Espiritu Santo, Barcelona); Jose Ales Martinez (Hospital RuberInternacional de Madrid, Madrid); Liliana Canosa Ruiz (Hospital Torrecardenas, Almeria); Margarita CentellesRuiz (Hospital SagratCor, Barcelona) United Kingdom John Allen Bridgewater John Bridgewater (North Middlesex University Hospital NHS Trust, London); Rob Glynne-Jones (Centre for Cancer Treatment, Mount Vernon Hospital, Northwood, London); SaadTahir (Broomfield Hospital, Chelmsford); TamasHickish (Poole Hospital NHS Trust, Poole and Bournemouth Hospital, Bournemouth); Jim Cassidy (Beatson West of Scotland Cancer Centre, Glasgow); Leslie Samuel (Aberdeen Royal Infirmary, Aberdeen) Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial datasetAnnals of OncologyVol. 25Issue 12PreviewThe prognostic value of KRAS mutations in colon adenocarcinoma is controversial. We examined this question as an ancillary study of the PETACC8 phase III trial. Full-Text PDF Open Archive